1. Home
  2. RCUS vs UTF Comparison

RCUS vs UTF Comparison

Compare RCUS & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$26.12

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Infrastructure Fund Inc

UTF

Cohen & Steers Infrastructure Fund Inc

HOLD

Current Price

$26.25

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
UTF
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
RCUS
UTF
Price
$26.12
$26.25
Analyst Decision
Buy
Analyst Count
11
0
Target Price
$30.27
N/A
AVG Volume (30 Days)
999.3K
352.1K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$247,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$45.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.06
$23.42
52 Week High
$26.40
$27.33

Technical Indicators

Market Signals
Indicator
RCUS
UTF
Relative Strength Index (RSI) 65.38 49.91
Support Level $19.62 $25.44
Resistance Level N/A $26.28
Average True Range (ATR) 1.56 0.30
MACD 0.30 -0.01
Stochastic Oscillator 69.54 21.98

Price Performance

Historical Comparison
RCUS
UTF

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. Under normal market conditions, the fund invests the majority of its managed assets in securities issued by infrastructure companies, which consist of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies.

Share on Social Networks: